PHILADELPHIA–(BUSINESS WIRE)– #biotechnology–Exegenesis Bio, a rapidly growing global gene therapy company, developing innovative genetic medicines for eye, CNS and liver-directed diseases is pleased to announce the appointment of Mahen Gundecha as …
Category: Business
Aerie Pharmaceuticals Announces Novel Dry Eye Product Candidate AR-15512 (TRPM8 Agonist) Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms and Signs in Successful Phase 2b Clinical Study for the Treatment of Dry Eye Disease
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Edgemont Partners Advises Tennessee Retina on its Sale to Retina Consultants of America
NEW YORK–(BUSINESS WIRE)–Edgemont Partners acted as exclusive financial advisor to Tennessee Retina on its Sale to Retina Consultants of America.
Glaukos Announces Settlement of Patent Litigation with Ivantis, Inc.
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
Global Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Age-Related Macular Degeneration Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. Global Age-Related Macular Degeneration Market and Competitive Landscape – 2021, …
Uveitis Drug Pipeline Landscape Research Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Uveitis – Drugs In Development, 2021, provides an overview of the Uveitis (Ophthalmology) pipeline landscape…
Global Refractive Surgery Devices Market (2021 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Refractive Surgery Devices Market Size, Share & Trends Analysis Report by Application (Myopia, Astigmatism), by Product (Lasers, Aberrometers), by End Use (Hospitals, Ambulatory Surgery Centers), and Segment For…
Opregen® Data Update Will Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D.
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today th…
Soleo Health Unveils Therapeutic Care Management Center Dedicated to Thyroid Eye Disease Patients
FRISCO, Texas–(BUSINESS WIRE)– #SoleoHealthTCMC–SOLEO HEALTH UNVEILS THERAPEUTIC CARE MANAGEMENT CENTER DEDICATED TO THYROID EYE DISEASE PATIENTS
Insights on the Ophthalmic Instrumentation Global Market to 2027 – Featuring Kowa, Leica Microsystems and Nidek Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Instrumentation – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Amid the COVID-19 crisis, the global market for Ophthalmic Instrumentation estimated at US$…
EyeSouth Partners Affiliates With Eye Center of St. Augustine, Representing the Network’s 25th Affiliation and Sixth Practice in Florida
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Eye Center of St. Augustine (“ECSA”). The affiliation represents EyeSouth’s sixth in the state of Florida and twe…
Retinopathy Of Prematurity (Ophthalmology) Drugs Pipeline Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinopathy Of Prematurity (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. The report provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipelin…
jCyte Announces Appointment of Victor Chao as Vice President of CMC Operations
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the continued expansion of the Company’s leadership team with the appointmen…
Infectious Endophthalmitis (Ophthalmology) Drug Pipeline Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Infectious Endophthalmitis (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information on the therapeutics under development for I…
Persistent Corneal Epithelial Defects Drugs Pipeline Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Persistent Corneal Epithelial Defects (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information on the therapeutics under develo…
Gemini Therapeutics Announces Presentation of Previously Released Data from Its Ongoing Phase 2a Study of GEM103 at EURETINA 2021 Virtual
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that Raj Maturi, M…
GenSight Biologics Announces Publication Analyzing Visual Parameters of ND4-LHON Subjects Before LUMEVOQ® Treatment in Phase III Trials
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Warby Parker Announces Investor Day
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc., a founder-led direct-to-consumer lifestyle brand, today announced that it will hold an Investor Day Monday, September 13th. The pre-recorded event will be available beginning at 11 a.m. ET/8:00 a.m. PT. Reg…
Exegenesis Bio Opens Philadelphia and Boston Offices and Announces Expansion Plans
PHILADELPHIA–(BUSINESS WIRE)–Global gene therapy company announces plans to create up to 50 new jobs in Philadelphia and Boston. Launches next phase in global expansion.
NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. The company presentation w…